ProfileGDS4718 / 210812_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 37% 37% 38% 29% 37% 43% 41% 35% 37% 37% 31% 41% 39% 40% 40% 34% 39% 40% 35% 42% 34% 35% 37% 37% 39% 36% 44% 33% 37% 37% 38% 36% 39% 38% 44% 44% 40% 39% 30% 39% 38% 40% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7983836
GSM549102patient 115, normal, homogenized [OPG study]4.8532637
GSM549104patient 119, normal, homogenized [OPG study]4.830237
GSM549108patient 138, normal, homogenized [OPG study]4.9306538
GSM549119patient 077, normal, homogenized [OPG study]4.5283329
GSM549133patient 032, cancer, homogenized [OPG study]4.7976437
GSM549139patient 042, cancer, homogenized [OPG study]5.0939843
GSM549099patient 107, normal, homogenized [OPG study]5.0434941
GSM549109patient 139, normal, homogenized [OPG study]4.760335
GSM549110patient 046, normal, homogenized [OPG study]4.8790737
GSM549114patient 063, normal, homogenized [OPG study]4.8206637
GSM549122patient 082, normal, homogenized [OPG study]4.5789631
GSM549134patient 033, cancer, homogenized [OPG study]5.0109841
GSM549136patient 036, cancer, homogenized [OPG study]4.8715639
GSM549140patient 044, cancer, homogenized [OPG study]4.9388140
GSM549111patient 047, normal, homogenized [OPG study]4.9542540
GSM549113patient 057, normal, homogenized [OPG study]4.674834
GSM549132patient 031, cancer, homogenized [OPG study]4.9295539
GSM549137patient 038, cancer, homogenized [OPG study]4.9474140
GSM549142patient 047, cancer, homogenized [OPG study]4.8836535
GSM549100patient 110, normal, homogenized [OPG study]5.1199142
GSM549107patient 135, normal, homogenized [OPG study]4.674834
GSM549115patient 068, normal, homogenized [OPG study]4.7042335
GSM549116patient 072, normal, homogenized [OPG study]4.819337
GSM549120patient 078, normal, homogenized [OPG study]4.8268737
GSM549131patient 030, cancer, homogenized [OPG study]4.8824139
GSM549118patient 074, normal, homogenized [OPG study]4.7974536
GSM549129patient 027, cancer, homogenized [OPG study]5.2042244
GSM549123patient 088, normal, homogenized [OPG study]4.6607133
GSM549124patient 006, cancer, homogenized [OPG study]4.8961737
GSM549126patient 015, cancer, homogenized [OPG study]4.837537
GSM549128patient 025, cancer, homogenized [OPG study]4.8767238
GSM549103patient 117, normal, homogenized [OPG study]4.8548636
GSM549117patient 073, normal, homogenized [OPG study]4.9243439
GSM549138patient 041, cancer, homogenized [OPG study]4.87338
GSM549141patient 045, cancer, homogenized [OPG study]5.1378444
GSM549130patient 028, cancer, homogenized [OPG study]5.1927344
GSM549101patient 111, normal, homogenized [OPG study]5.0486940
GSM549105patient 128, normal, homogenized [OPG study]4.953239
GSM549106patient 134, normal, homogenized [OPG study]4.4823530
GSM549112patient 048, normal, homogenized [OPG study]4.9310139
GSM549125patient 011, cancer, homogenized [OPG study]4.9243638
GSM549127patient 024, cancer, homogenized [OPG study]5.0047140
GSM549135patient 035, cancer, homogenized [OPG study]4.7774937